Vascular thromboembolic events in patients (pts) with advanced urothelial cancer (UC) treated with carboplatin/gemcitabine alone or in combination with bevacizumab

被引：0
|
作者：
Apolo, A. B. [1 ]
Regazzi, A. M. [1 ]
Milowsky, M. I. [1 ]
Bajorin, D. F. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5074
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The high incidence of vascular thromboembolic events (VTE) in advanced urothelial cancer (UC) patients (pts) treated with carboplatin (Cb): Analysis of treatment with gemcitabine (G)/cb (GCb), gcb/bevacizumab (GCbBev), or gemcitabine/cisplatin (GCis)
    Tully, Christopher Michael
    Apolo, Andrea Borghese
    Zabor, Emily C.
    Regazzi, Ashley Marie
    Ostrovnaya, Irina
    Rosenberg, Jonathan E.
    Bajorin, Dean F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [2] Phase II trial of gemcitabine, carboplatin, and bevacizumab (Bev) in patients (pts) with advanced/metastatic urothelial carcinoma (UC).
    Balar, A. V.
    Milowsky, M. I.
    Apolo, A. B.
    Ostrovnaya, I.
    Iasonos, A.
    Trout, A.
    Regazzi, A. M.
    Garcia-Grossman, I. R.
    Gallagher, D. J.
    Bajorin, D. F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [3] Phase II trial of gemcitabine, carboplatin, and bevacizumab in chemotherapy-naive patients (Pts) with advanced/metastatic urothelial carcinoma (UC)
    Balar, A. V.
    Milowsky, M. I.
    Apolo, A. B.
    Ostrovnaya, I.
    Iasonos, A.
    Trout, A.
    Regazzi, A. M.
    Garcia-Grossman, I. R.
    Gallagher, D. J.
    Bajorin, D. F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [4] Phase II Study of Gemcitabine, Carboplatin, and Bevacizumab in Patients With Advanced Unresectable or Metastatic Urothelial Cancer
    Balar, Arjun V.
    Apolo, Andrea B.
    Ostrovnaya, Irina
    Mironov, Svetlana
    Iasonos, Alexia
    Trout, Alisa
    Regazzi, Ashley M.
    Garcia-Grossman, Ilana R.
    Gallagher, David J.
    Milowsky, Matthew I.
    Bajorin, Dean F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06) : 724 - 730
  • [5] Combination paclitaxel, carboplatin, and gemcitabine is an active treatment for advanced urothelial cancer
    Hussain, M
    Vaishampayan, U
    Du, W
    Redman, B
    Smith, DC
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (09) : 2527 - 2533
  • [6] Risk for vascular thromboembolic events (VaTEs) in patients (pts) with advanced urinary tract cancer (aUTC) treated with chemotherapy.
    Bamias, Aristotelis
    Tsironis, George
    Dimitriadis, Ioannis
    Tzanis, Kimon
    Tsiara, Anna
    Xirokosta, Aikaterini
    Kaparelou, Maria
    Kyriazoglou, Anastasios
    Cohen, Abis
    Barbarousi, Despoina
    Koutsoukos, Konstantinos
    Liontos, Michael
    Zakopoulou, Roubini
    Kostouros, Euthymios
    Pagoni, Stamatina
    Matsouka, Charis
    Dimopoulos, Meletios A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [7] The Combination Chemotheray of Gemcitabine, Carboplatin and Bevacizumab in Patients with Advanced Non-Small Cell Lung Cancer
    Lee, Moon-Hyung
    Whang, Jin Ah
    Ahn, Young Mee
    Noh, Yong Ho
    Nam, Seung Hyun
    Kim, Bong-Seog
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S402 - S402
  • [8] THE COMBINATION CHEMOTHERAPY OF GEMCITABINE, CARBOPLATIN AND BEVACIZUMAB IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Kim, Bong Seog
    Ahn, Young Mi
    Lee, Moon Hyung
    Suh, Kang Heum
    Nam, Seung-Hyun
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1158 - S1158
  • [9] Molecular biomarker analysis and survival in patients (pts) with advanced urothelial cancer (UC) previously treated with chemotherapy.
    Szabados, Bernadett
    Rebelatto, Marlon
    Barker, Craig
    Milner, Alvin
    Lewis, Arthur
    Stokes, Michael
    Zajac, Magda
    Powles, Thomas
    Shire, Norah J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] THE COMBINATION CHEMOTHERAPY OF GEMCITABINE AND CARBOPLATIN-BEVACIZUMAB IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER
    Lim, T.
    Ahn, Y. M.
    Nam, S. -H.
    Kim, B. -S.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 147 - 147
12345